Physician profile
Sami U Khan
NPI 1043381791
$14,864.39
in general payments reported to CMS, 2019-2025
17 companies · $1,257 in 2025
The $1,257 reported for 2025 was more than what 75% of Plastic and Reconstructive Surgery providers received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $377 · 2020: $2,693 · 2022: $10K · 2023: $158 · 2024: $344 · 2025: $1,257.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,759.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,759.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tela Bio, INC. | $13,196.15 | 2019-2025 | Ovitex 2s, Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Integra Lifesciences Corporation | $347.56 | 2019-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Avita Medical Americas, LLC | $336.78 | 2024-2025 | Recell, Permeaderm, Cohealyx |
| Abbvie INC. | $187.24 | 2025 | |
| Sientra, INC. | $132.77 | 2019 | |
| Organogenesis INC. | $127.38 | 2024-2025 | Via Matrix |
| Polynovo North America LLC | $116.57 | 2025 | Novosorb Btm |
| Smith+Nephew, INC. | $108.87 | 2020-2025 | Collagenase Santyl, Pico |
| Innovation Technologies INC | $78.72 | 2025 | Irrisept |
| Shockwave Medical, INC | $60.85 | 2025 | |
| Aroa Biosurgery Incorporated | $37.00 | 2025 | |
| Access Pro Medical, LLC | $32.67 | 2025 | Matriderm |
| Musculoskeletal Transplant Foundation INC. | $25.65 | 2023-2025 | |
| Derma Sciences, INC. | $23.95 | 2019 | |
| Kci USA, INC. | $20.04 | 2023 | Prevena Restor Bellaform |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biocomposites INC | $19.24 | 2025 | Stimulan |
| Endo Pharmaceuticals INC. | $12.95 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sami Khan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.